SIOPE (the European Society for Paediatric Oncology) welcomes the opportunity to contribute to the EU Biotech Act consultation on behalf of the childhood cancer community. Cancer remains the leading cause of disease-related death in children and adolescents in Europe, yet innovation continues to bypass the specific needs of this population.
ESP
European Society for Paediatric Oncology (SIOP Europe, or SIOPE)
NGO · Belgium · EU Transparency Register 122803916413-09
3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #233 by legislative files engaged — a count of participation, not a measure of influence.
6.6
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2015
in the register since
Declares membership of
- https://siope.eu/activities/partnerships/
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Registered as
- European Society for Paediatric Oncology (SIOP Europe / SIOPE)
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track European in PolicySpeak: request access →
Work at European Society for Paediatric Oncology (SIOP Europe, or SIOPE)? so we know who speaks for it.
Their record over time
European Society for Paediatric Oncology (SIOP Europe, or SIOPE) filed 3 positions between 9 Jan 2024 and 2 Oct 2025, across 3 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2024 · 1 filed2025 · 2 filed
What they argued
SIOPE welcomes the European Innovation Act as a potentially useful instrument to shift gears in paediatric oncology innovation, and our aim is clear: to see more start-ups and biotech companies sustaining and scaling up innovation for children with cancer, namely start-ups focused on specific paediatric oncology drug development, including ATMPs.
The European Society for Paediatric Oncology (SIOP Europe, or SIOPE) is the only pan-European organisation representing all professionals working in the field of childhood cancers. The rarity and specificity of childhood cancers combined with their high overall burden in Europe require funding opportunities specifically addressing this disease area.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- Danish Industry · 2 files in common
- German Association of Biotechnology Industries (DIB) within the German Chemical Industry Association - VCI · 2 files in common
- MedTech Europe · 2 files in common
- BASF SE · 2 files in common
- Eurogroup for Animals · 2 files in common
Showing 5 of 32.
Is this your organization?
Everything on this page comes from European Society for Paediatric Oncology (SIOP Europe, or SIOPE)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.